Patents Assigned to Rexahan Corporation
  • Quinazoline derivatives and therapeutic use thereof
    Publication number: 20050187231
    Abstract: Quinazoline derivatives represented by the general formula pharmacologically acceptable salts thereof, and compositions containing such compounds are described. Methods for using the compounds for treatment of hyperproliferative disorders are also described.
    Type: Application
    Filed: February 17, 2005
    Publication date: August 25, 2005
    Applicant: Rexahan Corporation
    Inventors: Young Lee, Chang Ahn